Wave Life Sciences Slips as Obesity Data Falls Short
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
We compare the 2024 outlook for index funds and target date funds to help you choose the right retirement path.
23,982 articlesWave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Tech-driven gains keep the Nasdaq Composite in play as AI optimism fuels trading. This update tracks live nasdaq comp...
A veteran contrarian warns that the AI-driven Nasdaq rally resembles the dot-com era. Bitcoin sits at a crossroads as...
The stock market CAPE ratio has climbed near 40, a level last seen before major crashes in 1929 and 1999, prompting c...
Friday's strong jobs data complicates the Fed's rate path, signaling higher borrowing costs ahead while raising quest...
Purchase applications rose 7% week over week and 17% year over year, even as mortgage rates hover near cycle highs. A...
In 2026, Marvell Technology has become a focal point for investors. This article breaks down the drivers behind the r...
A leading market strategist argues the AI-led pullback is routine profit-taking after a rapid rally, with the AI infr...
Five-year horizons test even strong crypto theses. This article breaks down XRP's potential paths and practical steps...
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
A high-stakes debate is unfolding around SpaceX and its heavy short interest. This article breaks down what it means ...
In the wake of a Supreme Court ruling voiding emergency tariffs, Trump warns trading partners they could face far har...